UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

Journal of gastroenterology, 2022-05, Vol.57 (5), p.357-371

2022

Volltextzugriff (PDF)

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

Liver international, 2022-06, Vol.42 (6), p.1410-1422

2022

Volltextzugriff (PDF)

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Alimentary pharmacology & therapeutics, 2018-12, Vol.48 (11-12), p.1260-1270

2018

Volltextzugriff (PDF)

Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis

Scientific reports, 2021-04, Vol.11 (1), p.8250-8250, Article 8250

2021

Volltextzugriff (PDF)

Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus

Advanced science, 2021-06, Vol.8 (11), p.2004168-n/a

2021

Volltextzugriff (PDF)

Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver disease subjects

Liver international, 2021-09, Vol.41 (9), p.2076-2086

2021

Volltextzugriff (PDF)

Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease

EBioMedicine, 2021-08, Vol.70, p.103521-103521, Article 103521

2021

Volltextzugriff (PDF)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Scientific reports, 2016-08, Vol.6 (1), p.31421-31421, Article 31421

2016

Volltextzugriff (PDF)

Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Clinical gastroenterology and hepatology, 2020-01, Vol.18 (1), p.216-225.e5

2020

Volltextzugriff (PDF)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

Scientific reports, 2022-03, Vol.12 (1), p.3418-3418, Article 3418

2022

Volltextzugriff (PDF)

LiverAI: New tool in the landscape for liver health

Gastroenterología y hepatología, 2024-06, Vol.47 (6), p.646-648

2024

Volltextzugriff (PDF)

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

PloS one, 2020-12, Vol.15 (12), p.e0243590-e0243590

2020

Volltextzugriff (PDF)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Nature communications, 2016-09, Vol.7 (1), p.12757-12757, Article 12757

2016

Volltextzugriff (PDF)

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR

Journal of hepatology, 2019-03, Vol.70 (3), p.494-500

2019

Volltextzugriff (PDF)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)

International journal of molecular sciences, 2018-03, Vol.19 (3), p.911

2018

Volltextzugriff (PDF)

Novel insights into metabolic‐associated steatotic liver disease preclinical models

Liver international, 2024-03, Vol.44 (3), p.644-662

2024

Volltextzugriff (PDF)

Management of NAFLD patients with advanced fibrosis

Liver international, 2021-06, Vol.41 (S1), p.95-104

2021

Volltextzugriff (PDF)

An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high‐fat “Western‐type” diet in mice

Molecular nutrition & food research, 2017-03, Vol.61 (3), p.np-n/a

2017

Volltextzugriff (PDF)

Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD

Liver international, 2023-09, Vol.43 (9), p.1909-1919

2023

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(120)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis

Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus

Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver disease subjects

A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

LiverAI: New tool in the landscape for liver health

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′UTR

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)

Novel insights into metabolic‐associated steatotic liver disease preclinical models

Management of NAFLD patients with advanced fibrosis

An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high‐fat “Western‐type” diet in mice

Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD

Suchergebnisse filtern